Paper Title
A REVIEW ON ANTI-TUBERCULOSIS
Article Identifiers
Authors
Atole Nikita Janardhan , Ranjana Baban Gadadare , Taware Tejal Satish
Keywords
Tuberculosis treatment , HIV and TB co-infection , Mycobacterium tuberculosis , Anti -TB drug.
Abstract
ABSTRACT :- Tuberculosis( TB) is one of the most ancient conditions of humanity, with molecular substantiation going back to over 17,000 times. . In malignancy of newer modalities for opinion and treatment of TB, unfortunately, people are still suffering, and worldwide it's among the top 10 killer contagious conditions, second only to HIV. According to World Health Organization WHO), TB is a worldwide epidemic. It's a leading cause of death among HIV infected people. nonetheless, roughly 10 – 15 of cases have normal casket radiography .Although abnormalities are present, introductory hematologic and biochemical tests as well as tuberculin skin test are nonspecific for the opinion Only three new medicines, be daquiline (BDQ) and the two nitroimidazole derivations delamanid ( DLM) and pretomanid PMD) were approved in the last decade for treatment of TB — the first anti-TB medicines with new mode of conduct to be introduced to the request in further than 50 times — reflecting the wasterates in the development and blessing of new anti - TB drugs .Response to first- line anti -TB medicines is good as substantiated by numerous reports. This review aims to present a current update on circulated TB with emphasison the individual workup of this ruinous condition .Tuberculosis Is a major bluster to humanity repel to progress in health- care systems and the wide armament of TB control programs. The World Health Organization( WHO) estimated million individualities had TB, but only 6 million cases had been reported to the WHO. redundant pulmonary tuberculosis(EPTB) has an adding rate in Indian population
Downloads
How To Cite (APA)
Atole Nikita Janardhan, Ranjana Baban Gadadare, & Taware Tejal Satish (November-2023). A REVIEW ON ANTI-TUBERCULOSIS. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(11), c52-c64. https://ijnrd.org/papers/IJNRD2311208.pdf
Issue
Volume 8 Issue 11, November-2023
Pages : c52-c64
Other Publication Details
Paper Reg. ID: IJNRD_208623
Published Paper Id: IJNRD2311208
Downloads: 000121987
Research Area: Pharmacy
Country: SOLAPUR, MAHARASHTRA, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2311208.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2311208
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.
Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: October 2025
Current Issue: Volume 10 | Issue 10 | October 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Oct-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
